3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Unknown
1
Sponsor Class
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
19
Lung Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Ovarian Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous-Cell Lung Cancer
1
Small Cell Lung Carcinoma
1
Retinoblastoma
1
Retinal Neoplasms
1
Resectable Lung Non-Small Cell Carcinoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Cancer Recurrent
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
NSCLC
1
Head and Neck Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Carcinoma, Bronchogenic
1
Bronchial Neoplasms
1
Advanced Non Small Cell Lung Cancer
1
Adenocarcinoma of Lung
1
Interventions
Oxaliplatin
67
Capecitabine
60
Fluorouracil
58
Bevacizumab
54
Gemcitabine
51
Paclitaxel
50
Leucovorin
50
Irinotecan
40
Docetaxel
39
Carboplatin
39
Cisplatin
38
pembrolizumab
37
Nivolumab
37
Cetuximab
35
Sunitinib
25
Trastuzumab
24
Radiosurgery
24
Radiotherapy
21
Doxorubicin
21
Cyclophosphamide
21
Panitumumab
20
Drug Therapy
19
Pemetrexed
18
Everolimus
18
Sorafenib
17
Interleukin-2
16
Fulvestrant
16
Albumin-Bound Paclitaxel
16
atezolizumab
15
Erlotinib Hydrochloride
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Neoplasm Metastasis
×
Platinum Compounds
×
Clear all
NCT05136768
2021-11-29
LM-HNSCC
ChineseAMS
Phase 2
Unknown
50 enrolled